Abstract:ABSTRACT Drug addiction can seriously damage human physical and mental health, while detoxification is a long and difficult process. Although studies have reported changes in the oral microbiome of methamphetamine (METH) users, the role that the microbiome plays in the process of drug addiction is still unknown. This study aims to explore the function of the microbiome based on analysis of the variations in the oral microbiome and metabolome of METH users. We performed the 16S rRNA sequencing analysis based on the oral saliva samples collected from 278 METH users and 105 healthy controls (CTL). In addition, the untargeted metabolomic profiling was conducted based on 220 samples. Compared to the CTL group, alpha diversity was reduced in the group of METH users and the relative abundances of Peptostreptococcus and Gemella were significantly increased, while the relative abundances of Campylobacter and Aggregatibacter were significantly decreased. Variations were also detected in oral metabolic pathways, including enhanced tryptophan metabolism, lysine biosynthesis, purine metabolism, and steroid biosynthesis. Conversely, the metabolic pathways of porphyrin metabolism, glutathione metabolism, and pentose phosphate were significantly reduced. It was speculated that four key microbial taxa, i.e., Peptostreptococcus , Gemella , Campylobacter , and Aggregatibacter , could be involved in the toxicity and addiction mechanisms of METH by affecting the above metabolic pathways. It was found that with the increase of drug use years, the content of tryptamine associated with neuropsychiatric disorders was gradually increased. Our study provides novel insights into exploring the toxic damage and addiction mechanisms underlying the METH addiction. IMPORTANCE It was found that with the increase of drug use years, the content of tryptamine associated with neuropsychiatric disorders gradually increased. The prediction models based on oral microbiome and metabolome could effectively predict the methamphetamine (METH) smoking. Our study provides novel insights into the exploration of the molecular mechanisms regulating the toxic damage and addiction of METH as well as new ideas for early prevention and treatment strategies of METH addiction.

Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study

Neurotoxic Methamphetamine Doses Alter CDCel-1 Levels and Its Interaction with Vesicular Monoamine Transporter-2 in Rat Striatum

Methamphetamine presentations to an emergency department: Management and complications

Volumetric abnormalities of grey matter in methamphetamine dependent patients

Long-Term Methamphetamine Administration in the Vervet Monkey Models Aspects of a Human Exposure: Brain Neurotoxicity and Behavioral Profiles

Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities

Related Effects of Methamphetamine on the Intestinal Barrier via Cytokines, and Potential Mechanisms by Which Methamphetamine May Occur on the Brain-Gut Axis

Metabolomics Profiling of Methamphetamine Addicted Human Serum and Three Rat Brain Areas

Current Understanding of Methamphetamine-Associated Metabolic Changes Revealed by the Metabolomics Approach

Methamphetamine is not Toxic but Disrupts the Cell Cycle of Blood-Brain Barrier Endothelial Cells

Methamphetamine and the brain: Emerging molecular targets and signaling pathways involved in neurotoxicity

Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction

Involvement of serotonin mechanism in methamphetamine-induced chronic pulmonary toxicity in rats

Methamphetamine Poisoning Following "Plugging" Intentional Recreational Rectal Use

Methamphetamine and the Synthetic Cathinone 3,4-Methylenedioxypyrovalerone (MDPV) Produce Persistent Effects on Prefrontal and Striatal Microglial Morphology and Neuroimmune Signaling following Repeated Binge-like Intake in Male and Female Rats

Acute methamphetamine exposure inhibits cardiac contractile function

Comparison of striatal dopamine transporter levels in chronic heroin‐dependent and methamphetamine‐dependent subjects

Effects of Methamphetamine on Within- and Between-Network Connectivity in Healthy Adults

Variations in the oral microbiome and metabolome of methamphetamine users